Results 171 to 180 of about 6,454 (219)

Revolutionizing type 2 diabetes management: the role of the pharmacist in unlocking the potential of tirzepatide. [PDF]

Saudi Pharm J
Banji D, Alshahrani S, Alfarhan M, Banji OJF.   +3 more
europepmc   +1 more source

Correction to: "Tirzepatide-Induced Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Presenting With Seizures". [PDF]

JCEM Case Rep
europepmc   +1 more source

The relation between tirzepatide and adverse cardiovascular events or renal adverse events: a meta-analysis based on randomized controlled trials. [PDF]

Diabetol Metab Syndr
Liu L, Chen J, Zhang X, Zhu S, Dai T, Wu Q, Fang Y.   +6 more
europepmc   +1 more source

Comparative Safety of GLP-1 Receptor Agonists Across Gastrointestinal, Renal and Pancreatic Systems. [PDF]

Pharmaceuticals (Basel)
Shokr H, Mekkawy M, Hindi A.
europepmc   +1 more source

Dual incretin analogue tirzepitide - SURMOUNTing the challenge of obesity induced obstructive sleep apnea. [PDF]

World J Exp Med
Bajpai J, Saxena M, Agarwal U, Pradhan A.   +3 more
europepmc   +1 more source

Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices and insulin resistance beyond weight loss. [PDF]

Front Endocrinol (Lausanne)
Paternò V, Geraci G, Piticchio T, Le Moli R, Burgio S, Costanzo G, Sambataro G, Baratta R, Barbagallo F, Pallotti F.   +9 more
europepmc   +1 more source

Efficacy and Safety of Tirzepatide and Semaglutide for Obesity Management: A Real-World Comparison. [PDF]

Cureus
Shil KK, Hira AD, Bakchi S, Paul SK, Hossain M, Ghosh DK.   +5 more
europepmc   +1 more source

New-Onset Atrial Fibrillation Potentially Associated With Tirzepatide: A Case Report. [PDF]

Cureus
Purvez A, Mirza M, Bashir M.
europepmc   +1 more source

Tirzepatide modulates gut microbiota homeostasis to protect against diabetic kidney disease. [PDF]

Front Mol Biosci
Ma J, Tao M, Zhang W, Zhou L, Zhang H, Li F, Zhang H, Yao D, Lu W, Wang M.   +9 more
europepmc   +1 more source